In Brief: FDA good guidance policy implementation
This article was originally published in The Gray Sheet
FDA good guidance policy implementation: Agency holds a two-hour seminar Oct. 17 to train staffers in the Center for Devices and Radiological Health on how to comply with good guidance policy, which is aimed at standardizing and increasing public participation in the guidance development and revision process ("The Gray Sheet" March 3, I&W-1). Seven CDRH offices, along with every division, now have one staffer who are trained in GGP procedures and are responsible for ensuring compliance...
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.